Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Menopause. 2012 Jan;19(1):96–103. doi: 10.1097/gme.0b013e318223e82a

Table 1.

Average concentrations of ospemifene and 4-OH ospemifene in the tumors and plasma of mice in each cohort of the prevention and treatment experiments.

a.
Prevention 4-OH OSP OSP n

Group Plasma (nM) Tumor (nmol/g) Plasma (nM) Tumor (nmol/g)

Osp 5 mg/kg 96.5 0.05 72.6 0.07 7

Osp 25 mg/kg 760.2 0.35 446.3 1.71 8

Osp 50 mg/kg 2505.2 0.92 2013.2 4.04 8

Control animals (n=10) had no detectible peaks
b.
Treatment 4-OH OSP OSP n

Group Plasma (nM) Tumor (nmol/g) Plasma (nM) Tumor (nmol/g)

Osp 5 mg/kg 53.2 0.05 42.2 0.07 5

Osp 25 mg/kg 397.1 0.26 181.8 0.66 2

Osp 50 mg/kg 1015.4 0.99 1947.2 3.43 3

Control animals (n=10) had no detectible peaks